Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
				
				
           
			          As the largest hospital in the Twin Cities, Abbott Northwestern is recognized nationally and locally for its exceptional expertise and care. Each year, the hospital serves more than 200,000 patients and their families from across the Twin Cities and Upper Midwest.
Our hospital has a long and proud history as a health care provider and innovator in Minneapolis. The following tells the story of how Abbott Northwestern was built from a collection of great health care organizations into a leading regional medical center and the Twin Cities largest non-profit hospital.
We've found
        5 trials
        at this facility
      	
	Breast Cancer Clinical Trial
	
Updated: 12/6/2012
  
  
  Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/6/2012
Click here to add this to my saved trials
	    
	 
  	
	Oncology Clinical Trial
	
Updated: 12/5/2012
  
  
  Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
		Status: Enrolling	
	Updated: 12/5/2012
Click here to add this to my saved trials
	    
	 
  	
	Esophageal Cancer Clinical Trial
	
Updated: 3/15/2011
  
  
  Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/15/2011
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Oncology, Psychiatry / Psychology Clinical Trial
	
Updated: 11/9/2012
  
  
  Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
		Status: Enrolling	
	Updated: 11/9/2012
Click here to add this to my saved trials
	    
	 
  	
	Breast Cancer Clinical Trial
	
Updated: 9/20/2012
  
  
  Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	Updated: 9/20/2012
Click here to add this to my saved trials
	    
	